Article ID Journal Published Year Pages File Type
3070970 Neurobiology of Disease 2007 12 Pages PDF
Abstract

Aberrant handling of Amyloid Precursor Protein (APP) and β-amyloid (Aβ), glial activation and inflammation are key events in Alzheimer’s disease. We set out to determine the role of inflammation on microglial reactivity against APP. We studied microglia-mediated neurotoxicity, uptake and degradation of a biotinylated APP construct (biotin-APP-C-244). APP, in contrast to Aβ, only induced mild activation of glial cells. However, under pro-inflammatory conditions, APP induced microglial-mediated cytotoxicity. Biotin-APP-C-244 or lipopolysaccharide and interferon-gamma (LPS + IFNγ), administered separately, did not change reduction metabolism of microglia. However, biotin-APP-C-244 + (LPS + IFNγ) increased microglial reactivity and decreased reduction metabolism by 75% (P < 0.001). Biotin-APP-C-244 was readily taken up by microglial cells; 80% was phagocytosed at 2 h. In the presence of LPS + IFNγ, phagocytosis of biotin-APP-C-244 was reduced at 2 h; and cell damage was evident after 4 h. Our results support our hypothesis that, in neuroinflammation, microglial scavenger function is impaired and reactivity against APP enhanced as an initial step for neurodegeneration.

Related Topics
Life Sciences Neuroscience Neurology
Authors
, , , ,